Teva Pharmaceuticals Sicor
Directory listingDirectory record status
These labels describe this UNITEMFG record. They do not guarantee current capabilities, certifications, capacity, quality, or fit for a specific job.
- Directory listing
- Listed
- Ownership
- Unclaimed
- Last profile update
- Aug 14, 2026
About
Subsidiary of Teva Pharmaceuticals USA specializing in development and marketing of generic injectables. Focuses on oncolytic and specialty injectable products with internal Research and Development capabilities, operational flexibility and manufacturing expertise. Offers nearly 20 oncolytic and 30 specialty injectable products with emphasis on complex generic formulations.
Specialties
Manufacturing Capabilities
Processes
Certifications & Quality
Business Certifications
Source-backed capabilities
These capability statements were observed in the linked manufacturer sources. They are source evidence, not a certification of the company or its current capacity.
Certification
- cGMP
substantial amount of our own active pharmaceutical ingredients. That allows us to closely control product quality. But we’re just as strict on our external suppliers, who must meet the same tough requirements we set for ourselves. As a result, we have an enviable record of Current Good Manufacturing Practice (cGMP) compliance, which is assessed by the US Food and Drug Administration (FDA) and other global regulatory organizations. World’s Leading Manufacturer of Generic Pharmaceuticals As
Teva Pharmaceuticals Sicor certification evidence ↗ Observed Aug 14, 2026